59
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0957 |
Isradipine
PN 200-110,伊拉地平 |
Calcium Channel; Autophagy | Autophagy; Membrane transporter/Ion channel; Metabolism |
Isradipine (PN 200-110) 是一种二氢吡啶类钙通道阻滞剂,具有抗高血压和血管扩张活性。它是一种具有口服活性的 L 型钙通道阻滞剂,也是一种潜在可行的帕金森病神经保护剂。 | |||
T21447 |
Tolazoline
Priscol,妥拉苏林,Priscoline,Pridazole,Divascol,Vasimid,Benzalolin |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Tolazoline (Benzalolin) 是一种竞争性的α-肾上腺素受体拮抗剂。 | |||
T16411 |
Otenzepad
AF-DX 116 |
AChR | Neuroscience |
Otenzepad (AF-DX 116) 是 M2 mAChR 的特异性拮抗剂,对大鼠心脏和兔外周肺的 IC50 分别为 386 nM 和 640 nM。 | |||
T10244 |
ACY-1083
|
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
ACY-1083 是一种选择性和脑穿透性 HDAC6 抑制剂 (IC50:3 nM),可有效逆转化疗引起的周围神经病变。 | |||
T0806 |
Flunarizine dihydrochloride
Flunarizine 2HCl,KW-3149,R14950,盐酸氟桂利嗪 |
Calcium Channel; Dopamine Receptor; Sodium Channel | GPCR/G Protein; Membrane transporter/Ion channel; Metabolism; Neuroscience |
Flunarizine dihydrochloride (R14950) 是 Na+/Ca2+(T 型) 通道双重阻滞剂。它也是 D2多巴胺受体拮抗剂。它具有用于扩张外周血管和预防偏头痛的潜力。 | |||
T5385 |
Radiprodil
RGH-896 |
NMDAR; iGluR | Membrane transporter/Ion channel; Neuroscience |
Radiprodil (RGH-896) 是一种具有口服活性的、NMDA 受体 NR2B 亚类的选择性拮抗剂。它有用于神经性疼痛和其它慢性疼痛的相关研究潜力。 | |||
T2371 |
Emapunil
AC-5216,XBD-173 |
Others | Others |
Emapunil (XBD-173) 是一种选择性的、口服有效的TSPO(一种线粒体苯二氮受体) 的配体。在多种动物模型中,它显示出抗焦虑和抗抑郁特性。 | |||
T10998 |
Deriglidole
SL 86-0715 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Deriglidole (SL 86-0715) 是一种外周肾上腺素能受体拮抗剂,是一种具有选择性的α2受体抑制剂。 Deriglidole 对可乐定和 Idazoxan 有抑制作用而对哌唑嗪与大鼠皮质和人血小板α2-肾上腺素能受体不显示活性。 | |||
T10073 |
2-Iodomelatonin
|
Melatonin Receptor | GPCR/G Protein |
2-Iodomelatonin 是褪黑激素受体 1 (MT1) 的强效激动剂,Ki 为 28 pM,对 MT1的选择性是 MT2 的 5 倍以上。2-Iodomelatonin 可用于鉴定,表征和定位脑和周围组织的褪黑激素结合位点。 | |||
TP1918L1 |
Lys-[Des-Arg9]Bradykinin acetate
Lys-[Des-Arg9]Bradykinin acetate (71800-36-7 free base) |
Bradykinin Receptor | GPCR/G Protein |
Lys-[Des-Arg9]Bradykinin acetate (71800-36-7 free base) 是一种内源性强效和高选择性的缓激肽 B1 受体激动剂(对人 B1 和 B2 受体的 Ki 值分别为 0.12 和 > 30000 nM)。降低体内外周血管阻力的降压药。比 [Des-Arg9]-缓激肽强 16 倍。 | |||
TP1918L |
Lys-[Des-Arg9]Bradykinin,TFA
Lys-[Des-Arg9]Bradykinin,TFA 71800-36-7(fb-tfa) |
Bradykinin Receptor | GPCR/G Protein |
Lys-[Des-Arg9]Bradykinin,TFA (71800-36-7 free base) 是内源性强效和高选择性的缓激肽 B1 受体激动剂(对人 B1 和 B2 受体的 Ki 值分别为 0.12 和 > 30000 nM)。降低体内外周血管阻力的降压药。比 [Des-Arg9]-缓激肽强 16 倍。 | |||
T13664 |
DSP-4 hydrochloride
Neurotoxin DSP 4 (hydrochloride) |
Others | Others |
DSP-4 hydrochloride (Neurotoxin DSP 4 (hydrochloride)) 是一种高选择性的神经毒素,主要是来自蓝斑 (LC) 的神经元,容易通过血脑屏障。它对成年和发育中大鼠去甲肾上腺素能神经元具有神经毒性作用,可用于中枢和外周去甲肾上腺素能神经元的暂时选择性降解。 | |||
T2525 |
Alosetron hydrochloride
Lotronex,盐酸阿洛司琼,GR 68755C,GR 68755,GR 68755X |
5-HT Receptor | GPCR/G Protein; Neuroscience |
Alosetron hydrochloride (GR 68755) 是一种高选择性的 5-HT3 受体拮抗剂,可减轻清醒或麻醉犬直肠扩张的内脏伤害性效应,具有抗炎活性,用于肠易激综合征的研究。它阻断 5HT3 介导的豚鼠肌间和粘膜下神经元的快速去极化,IC50约为 55 nM。 | |||
T1050 |
Prazosin hydrochloride
Prazosin hydrochloride,哌唑嗪盐酸盐,Prazosin HCl,cp-12299-1,Peripress,Vasoflex,盐酸哌唑嗪,Minipress |
Potassium Channel; MRP; Adrenergic Receptor; ABC; Autophagy | Autophagy; GPCR/G Protein; Immunology/Inflammation; Membrane transporter/Ion channel; Neuroscience |
Prazosin hydrochloride (Vasoflex) 是一种选择性肾上腺素能 α-1 拮抗剂,可降低外周阻力并放松血管平滑肌。 它可用于研究高血压和酒精使用障碍。 它是一种合成哌嗪衍生物,具有降压抗肾上腺素能特性。它抑制有机阳离子转运蛋白 OCT-1 和 OCT-3,IC50分别为 1.8 和 13 μM 。 | |||
TP1992L |
M40 acetate(143896-17-7 free base)
|
Neuropeptide Y Receptor | GPCR/G Protein; Neuroscience |
M40 acetate(143896-17-7 free base) 是一种有效的、非选择性的甘丙肽受体拮抗剂(GAL1 和 GAL2 的 Ki 值分别为 1.82 和 5.1 nM),在体外抑制大鼠脑中甘丙肽 (1-29) 的结合 (IC50 = 3 - 15 nM)。减弱氟西汀的抗抑郁作用并阻止甘丙肽诱导的体内食物摄入。在剂量 > 100 nM 时,对外周 GAL2 受体也表现出较弱的部分激动剂活性。 | |||
T3173 |
DAA-1106
DAA1106 |
Others; GABA Receptor | Membrane transporter/Ion channel; Neuroscience; Others |
DAA-1106是外周苯二氮受体激动剂。 | |||
T25102 |
Aprikalim
RP52891,RP-52891,RP 52891 |
||
Aprikalim is a specific and selective ATP-sensitive K+ (KATP) channel opener. Aprikalim affords cardioprotection and at higher doses also cause peripheral or coronary vasodilatation. | |||
T21392 |
Flunarizine
Flunarizinum,Flunarizin,Sibelium,Flunarizina,R-14950 |
||
Flunarizine is a non-selective calcium entry blocker and a histamine H1 receptor blocker. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of | |||
T27324 |
FK614
FK 614,ATx-08-001,ATx-08001,FK-614 |
||
FK-614 is a selective agonist of peroxisome proliferator-activated receptor gamma. FK-614 improves peripheral glucose utilization while decreases hepatic insulin extraction in alloxan-induced diabetic dogs. | |||
T11323L | Frakefamide | Others | Others |
Frakefamide is a potent analgesic. It acts as a peripheral active μ-selective receptor agonist. Frakefamide is unable to penetrate the blood-brain-barrier and enter the central nervous system. | |||
T29933 |
AM-1714
UNII-E3OY6PCU04,AM1714 |
||
AM-1714 is a reasonable selective agonist for the peripheral cannabinoid receptor CB2. In animal studies, it has been shown to have analgesic and anti-abnormal pain effects. | |||
T11482 | GSK2245035 | Others | Others |
GSK2245035 is a highly selective intranasal TLR7 agonist with preferential Type-1 interferon (IFN)-stimulating properties (pEC50s: 9.3 and 6.5 for IFNα and TFNα). It effectively suppresses allergen-induced Th2 cytokine production in human peripheral blood | |||
T28335 |
PD 140376
PD-140376,PD140376 |
||
PD 140376 is a highly selective antagonist radioligand for the cholecystokinin(B)-gastrin receptor in guinea pig gastric mucosa & cerebral cortex in the peripheral and central nervous systems. | |||
T14570 |
BI 99179
BI99179 |
Fatty Acid Synthase | Metabolism |
BI99179 is a potent and selective type I fatty acid synthase (FAS) inhibitor with an IC50 of 79 nM and it exhibits significant exposure (both peripheral and central) upon oral administration in rats[1]. | |||
T14938 |
CGP 36742
SGS-742 |
GABA Receptor | Membrane transporter/Ion channel; Neuroscience |
CGP 36742 is a selective antagonist of the GABAB receptor that can penetrate the blood-brain barrier after peripheral administration (IC50: 32 μM). It is useful in the treatment of depression. | |||
TQ0002L |
A-317491 sodium
A-317491,A 317491,A317491 |
||
A-317491 is an effective selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, which reverses inflammatory mechanical hyperalgesia and relieves chronic inflammation and neuropathic pain in rats by acting on peripheral receptors. | |||
T33583 |
Naldemedine
S-297995,S297995,Naldemedine,S 297995,S297,995,S 297,995,S297,995;Naldemedine,S-297,995 |
||
Naldemedine (S 297995) is a peripheral selective μ-opioid receptor antagonist being developed by Shionogi for the treatment of opioid-induced adverse reactions, including constipation, nausea, and vomiting. They are usually well tolerated, mainly with mil | |||
T11323 |
Frakefamide TFA (188196-22-7 free base)
Frakefamide TFA |
Others | Others |
Frakefamide is unable to penetrate the blood-brain-barrier and enter the central nervous system. Frakefamide TFA is a potent analgesic that acts as a peripheral active μ-selective receptor agonist. | |||
T28850 |
SR57227A
SR 57227A,SR-57227A |
||
SR 57227A is a highly selective of peripheral and central 5-HT3 receptors and an inhibitor of NMDA receptor-mediated responses in rat cortical pyramidal cells. It exhibits anti-depressant like effects in rats and decreased isolation-induced aggressive beh | |||
T14374 |
AZD2906
|
||
AZD2906, a selective glucocorticoid receptor (GR) agonist, demonstrates inhibitory concentrations (IC50s) of 2.2 nM in human GR, 0.3 nM in rat peripheral blood mononuclear cells (PBMC), 41.6 nM in human whole blood, and 7.5 nM in rat whole blood, respectively[1]. Additionally, it induces an increase in micronucleated immature erythrocytes within rat bone marrow. | |||
T41183 |
Helianorphin-19
|
||
Helianorphin-19 is a high affinity, potent and selective κ-opioid receptor (KOR) agonist (Ki = 25 nM; EC50= 45 nM). Helianorphin-19 exhibits approximately 200-fold selectivity for KOR over μ and δ-opioid receptors.In vivoHelianorphin-19 shows potent peripheral analgesic efficacy in a mouse model of visceral pain without affecting motor coordination/sedation. | |||
TP1918 |
Lys-[Des-Arg9]Bradykinin
|
||
Endogenous potent and highly selective bradykinin B1 receptor agonist (Ki values are 0.12 and > 30000 nM at human B1 and B2 receptors respectively). Hypotensive agent that reduces peripheral vascular resistance in vivo. 16-fold more potent than [Des-Arg9] | |||
T79303 |
IACS-52825
|
||
IACS-52825是一种选择性DLK抑制剂,具有1.3 nM的Kd值,适用于研究化疗引起的周围神经病变。 | |||
T73655 | Frakefamide TFA | ||
Frakefamide TFA 是一种有效的止痛药物,作为μ 受体的选择性外围激动剂。该化合物不能穿透血脑屏障,因此不进入中枢神经系统。 | |||
T61850 |
Adenosine receptor inhibitor 1
|
||
Adenosine receptor inhibitor 1 is a highly potent and selective antagonist of adenosine receptor (AR). It exhibits exceptional affinity for A1 AR, A2A AR, A2B AR, and A3 AR, with respective Ki values of >1000, 68.5, >1000, >1000 nM. This compound demonstrates notable antinociceptive, anti-inflammatory, and peripheral analgesic properties. Therefore, Adenosine receptor inhibitor 1 holds great promise for investigating cancer and neurodegenerative diseases [1]. | |||
TP1992 |
M40
|
||
Potent, non-selective galanin receptor antagonist (Ki values are 1.82 and 5.1 nM at GAL1 and GAL2 respectively) that inhibits galanin (1-29) binding in rat brain in vitro (IC50 = 3 - 15 nM). Attenuates the antidepressant effects of fluoxetine and blocks galanin-induced food intake in vivo. Also exhibits weak partial agonist activity at peripheral GAL2 receptors at doses > 100 nM. | |||
T79195 |
Cav 3.2 inhibitor 4
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
Cav 3.2 inhibitor 4 (compound 21) 是高效的选择性 T 型钙通道 (Cav3.2) 抑制剂,具有外周限制性,其 IC50 值为 0.6 μM,适用于心房颤动研究。 | |||
T36109 |
L Moses dihydrochloride
|
||
High affinity and selective cell-permeable p300/CBP-associated factor (PCAF) inhibitor (Ki = 47 nM). Exhibits no significant activity against a panel of 48 other bromodomains except GCN5 (Kd = 600 nM). Exhibits >4500-fold selectivity for PCAF over BRD4. Also exhibits metabolic stability in mouse and human liver microsomes and no observable cytotoxicity in peripheral blood mononuclear cells (PBMC). Moustakim et al (2017) Discovery of a PCAF bromodomain chemical probe. Angew.Chem.Int.Ed. 56 827 P... | |||
T21411 |
Isoproterenol
Norisodrine,Isoprenaline,Novodrin,Isuprel,Medihaler-Iso |
Endogenous Metabolite; Adrenergic Receptor | GPCR/G Protein; Metabolism; Neuroscience |
Isoproterenol (Norisodrine) 是一种非选择性且具有口服活性的 β-肾上腺素受体激动剂。Isoproterenol 是有效的外周血管扩张剂和支气管扩张剂。Isoproterenol 可用于研究心动过缓和支气管哮喘,用于治疗心脏传导阻滞、心动过缓。 | |||
T62541 | AChE-IN-22 | ||
AChE-IN-22 (compound 10q) 是一种乙酰胆碱酯酶 (AChE) 的选择性抑制剂,能够作用于 AChE (IC50: 0.88 μM) 和 BuChE (IC50: 10 μM)。AChE-IN-22 能够同时与 AChE 的 CAS (catalytic active site) 和 PAS (peripheral anionic site) 位点结合,可用于研究阿尔茨海默病。 | |||
T73522 |
CR 665
FE 200665,JNJ 38488502 ; FE 200665,JNJ 38488502 |
||
CR 665 (JNJ 38488502) 是一种外周选择性κ-阿片类激动剂。CR 665可以激活 kappa 阿片受体 EC50值为10.9 nM。CR 665 可用于外周疼痛的研究。 | |||
T82515 |
E104
|
||
E104(compound 1)为一种高效且选择性的TLR7激动剂,适用于ADC合成,以激发显著的抗癌活性。该化合物能够诱导小鼠巨噬细胞与hPBMC的活化。 | |||
T63173 | BTK-IN-8 | ||
BTK-IN-8 是一种有效的、选择性的、外周共价 BTK 抑制剂,其 IC50 值为 0.22 nM,Kd 值为 0.91 nM。BTK-IN-8 表现出良好的全血 CD69 细胞效力,其 IC50 值为 0.029 μM。 | |||
T40572 |
Lesogaberan napadisylate
AZD-3355 napadisylate |
||
Lesogaberan (AZD-3355) napadisylate is a potent and selective agonist of GABA B receptors, with an EC 50 of 8.6 nM for human recombinant GABA B receptors. It demonstrates an affinity (Ki) of 5.1 nM for rat GABA B receptors and 1.4 μM for GABA A receptors, as determined by its displacement of [3H]GABA binding in brain membranes. Notably, Lesogaberan napadisylate exerts a peripheral mode of action, inhibiting transient lower esophageal sphincter relaxation. | |||
T62732 | S1P1 agonist 5 | ||
S1P1 agonist 5 是一种选择性的、口服具有活力的 S1P1 激动剂。S1P1 agonist 5 可以抑制淋巴细胞从淋巴组织排出到外周血。S1P1 agonist 5 具有潜力进行多发性硬化症 (MS) 的研究。 | |||
T63287 | HPK1-IN-3 | ||
HPK1-IN-3 是一种选择性的、有效的、ATP 竞争性的造血祖细胞激酶 1 (HPK1; MAP4K1) 抑制剂 (IC50: 0.25 nM)。HPK1-IN-3 具有 IL-2 细胞效力,能够作用于人外周血单核细胞 (PBMC),EC50 值为 108 nM。 | |||
T71955 |
C3001a
|
||
C3001a is a selective activator for TREK, against other two-pore domain K+(K2P) channels. C3001a binds to the cryptic binding site formed by P1 and TM4 in TREK-1. C3001a targets TREK channels in the peripheral nervous system to reduce the excitability of nociceptive neurons. In neuropathic pain, C3001a alleviated spontaneous pain and cold hyperalgesia. In a mouse model of acute pancreatitis, C3001a alleviated mechanical allodynia and inflammation. C3001a represents a lead compound which could a... | |||
T69081 | KRH-1636 | ||
KRH-1636 is an orally active, selective and extremely potent CXC chemokine receptor 4 antagonist. KRH-1636 exhibits a potent and selective anti-HIV-1 activity. KRH-1636 efficiently blocked replication of various T cell line-tropic (X4) HIV type 1 (HIV-1) in MT-4 cells and peripheral blood mononuclear cells through the inhibition of viral entry and membrane fusion via the CXC chemokine receptor (CXCR)4 coreceptor but not via CC chemokine receptor 5. KRH-1636 also inhibits binding of the CXC chem... | |||
T37273 |
BLX3887
|
||
BLX3887 is an inhibitor of 15-lipoxygenase type 1 (15-LO-1; IC50 = 32 nM in a cell-free enzyme assay).1 It is selective for 15-LO-1 over 15-LO-2, which it does not inhibit, 5-LO (IC50 = 472 nM), and 12-LO (IC50 = 3,310 nM). BLX3887 inhibits the production of 15-LO metabolites selectively in eosinophils over neutrophils when used at a concentration of 10 μM. It also inhibits endocytosis in, and the migration of, isolated human peripheral blood mononuclear cell-derived dendritic cells in vitro. |1... | |||
T37523 |
Tenofovir diphosphate (sodium salt)
|
||
Tenofovir diphosphate is an inhibitor of HIV reverse transcriptase (Kis = 0.022 and 1.55 μM for RNA and DNA, respectively) and hepatitis B virus (HBV) polymerase (Ki = 0.18 μM). It is selective for these enzymes over DNA polymerase α and β, as well as mitochondrial DNA polymerase γ (Kis = 5.2, 81.7, and 59.5 μM, respectively). Tenofovir diphosphate is formed intracellularly through phosphorylation of the prodrugs tenofovir and tenofovir disoproxil by nucleotide kinases. Increased levels of tenof... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN2322 |
Yangambin
|
Calcium Channel; PAFR | GPCR/G Protein; Membrane transporter/Ion channel; Metabolism |
Yangambin 是从诸如番荔枝科植物中分离出来的呋喃木脂素,是选择性PAF 受体拮抗剂,通过调控Ca2+通道抑制 Ca2+流入,导致 [Ca2+]i 在血管平滑肌细胞和随后的外周血管舒张中减少,具有降压作用。 |